A disintegration test for evaluation of drug availability from tablets and capsules
Sandell, E.; Eriksson, K.; Mellström, G.
Acta Pharmaceutica Suecica 7(5): 559-566
1970
ISSN/ISBN: 0001-6675 PMID: 5275191 Document Number: 20228
Document emailed within 1 workday
Related Documents
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87Cascioli, D.; Petrangeli, B. 1978: Drug absorption and bioavailability problems of tablets and capsules Bollettino Chimico Farmaceutico 117(8): 437-451
Northern, R.E.; Lach, J.L.; Fincher, J.H. 1973: Dissolution-dialysis method of assessing in vitro drug availability of prednisolone tablets American Journal of Hospital Pharmacy 30(7): 622-627
Khalil, S.A.; Ali, L.M. 1972: Some formulation factors affecting disintegration and dissolution of chloramphenicol capsules Acta Pharmaceutica Suecica 9(6): 563-572
Couvreur, P.; Gillard, J.; Van den Schrieck, H.G.; Roland, M. 1974: Mechanism of disintegration of tablets with a starch base Journal de Pharmacie de Belgique 29(5): 399-414
Colombo, P.; Ferrari, F.; Gazzaniga, A.; Caramella, C.; Conte, U.; La Manna, A.; Peppas, N.A. 1988: Simulation of the disintegration process of pharmaceutical tablets Pharmaceutica Acta Helvetiae 63(8): 221-223
Realdon, N.; Ragazzi, E. 2000: Effect of operating parameters on the in vitro drug availability test from suppositories Die Pharmazie 55(12): 954-955
Miseta, M.; Pintyéné Hódi, K.; Szabóné Révész, P. 1995: Water uptake of tablets, their disintegration and dissolution are in close relation Acta Pharmaceutica Hungarica 65(2): 33-39
Butler, K. 1973: Biological availability of oxytetracycline HC1 capsules Revue Canadienne de Biologie 32(Suppl): 53-67
Fell, J.T. 1983: Esophageal transit of tablets and capsules American Journal of Hospital Pharmacy 40(6): 946; 948
Yamauchi, M.; Kondo, T. 1995: Evaluation of drug sensitivities to gastric cancers by Sdi test--study of quality control of Sdi test by simulation test Human Cell 8(4): 163-172
Sekulović, D.; Birmancević, M. 1986: The investigation of the disintegration time of tablets with metamizol and propyphenazone prepared by the method of direct compression Die Pharmazie 41(4): 294
Marvola, M.; Hannula, A.M.; Ojantakanen, S.; Westermarck, E.; Rajamäki, M. 1989: Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog Acta Pharmaceutica Nordica 1(6): 355-362
Ondari, C.O.; Prasad, V.K.; Shah, V.P.; Rhodes, C.T. 1984: Effects of short-term moderate storage stress on the disintegration and dissolution of four types of compressed tablets Pharmaceutica Acta Helvetiae 59(5-6): 149-153
Innes, J.A.; Campbell, I.W.; Millar, J.; Munro, J.F. 1975: A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules Postgraduate Medical Journal 51(Suppl 1): 160-162
Hom, F.S.; Veresh, S.A.; Miskel, J.J. 1971: Ultraviolet spectrophotometric determination of propylthiouracil in assays and dissolution studies of tablets and capsules Journal - Association of Official Analytical Chemists 54(6): 1420-1422
Shoaib, M.H.; Tazeen, J.; Merchant, H.A.; Yousuf, R.I. 2006: Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC Pakistan Journal of Pharmaceutical Sciences 19(2): 119-124
Sinterhauf, K.; Bechtel, W.D. 1980: Plasma levels and renal excretion of [3H]-codeine phosphate in humans receiving tablets or depot capsules Arzneimittel-Forschung 30(6): 1012-1015
Tomassini, L.; Michailova, D.; Naplatanova, D.; Slavtschev, P. 1979: The effects of various factors on the in vitro velocity of drug release from repository tablets. Part 4: Isoniazid (Rimicid) respository tablets Die Pharmazie 34(12): 812-814
Chodkowska-Granicka, B.; Pawlak, Z.; Pawlak, E.; Surowiecki, J. 1972: Tablets of 7-(3'-(methylhydroxylethylamino)-2'-hydroxypropyl)-theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets Acta Poloniae Pharmaceutica 29(6): 618-622